Cato Research Neuland India, the new joint venture company formed by Cato Research, Cato Research Israel and Neuland will assist health care companies in efficiently bringing innovative drugs to market while using high quality and cost effective resources located in India.
Cato Research will provide business development, personnel training, senior management recruitment and implementation of SOP guidelines. In collaboration with Cato BioVentures, the venture capital affiliate of Cato Research, Cato Research will also provide CRO services to include clinical studies, data management activities, statistical analysis, as well as regulatory services.
Allen Cato, CEO of Cato Research, said: “This joint venture further allows Cato to expand its international presence and better serve our sponsors. The addition of India into Cato Research’s international network increases our ability to conduct multinational clinical trials and provide a wide range of CRO services in the international arena.”